Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 121 - 140 of 292
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jul 2015, 11:52 am by Schachtman
Merrell Dow Pharmaceuticals Inc., 43 F.3d 1311, 1320 (9th Cir.), cert. denied 516 U.S. 869 (1995) [Daubert II]. [read post]
14 Jul 2015, 6:41 am by Ellen Houston
Merrell Dow Pharmaceuticals, Inc., the landmark case that sets forth the test for the admissibility of expert testimony. [read post]
1 Jul 2015, 7:34 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and related cases.[6]” The court in Ladd Furniture v. [read post]
16 Jun 2015, 7:22 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993) (specifying the “the known or potential rate of error” as one of several factors in assessing the scientific reliability or validity of proffered expert witness’s opinion) Kumho Tire Co. v. [read post]
9 Jun 2015, 5:54 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), and (3) the testimony assists the trier of fact through the application of scientific, technical, or other specialized expertise. [read post]
28 May 2015, 2:29 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993). [read post]
14 May 2015, 2:15 pm by Maureen Johnston
Merrell Dow Pharmaceuticals and its progeny, permits a district court to require epidemiological evidence as a precondition for admissibility of a qualified expert's opinion that a toxic substance is capable of causing a particular disease. [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
30 Mar 2015, 2:01 pm by Joe O'Neill
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Kumho Tire Co. v. [read post]
3 Jan 2015, 3:47 pm by Robert Kreisman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and granted BNSF’s motion for summary judgment. [read post]
12 Nov 2014, 8:01 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 599 (1993) (Rehnquist, C.J., concurring in part and dissenting in part) (‘‘the various briefs filed in this case … deal with definitions of scientific knowledge, scientific method, scientific validity, and peer review—in short, matters far afield from the expertise of judges’’); Marconi Wireless Telegraph Co. of America v. [read post]
15 Sep 2014, 10:45 pm by Kristin Casler
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579, 592, 113 S.Ct. 2786, 125 L.Ed.2d 469 [1993]), the panel said. [read post]
15 Sep 2014, 10:45 pm by Kristin Casler
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579, 592, 113 S.Ct. 2786, 125 L.Ed.2d 469 [1993]), the panel said. [read post]
10 Sep 2014, 9:00 am by Maureen Johnston
Merrell Dow Pharmaceuticals regarding important expert testimony requires the appellate court to order a new trial, regardless of whether there was actually any substantive error in the expert testimony heard or not heard by the jury. [read post]
9 Sep 2014, 10:36 pm by Kristin Casler
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 [1993]),The U.S. [read post]